赢8娱乐糖果配对游戏-官方网站[welcome]


+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 68064

Chapter 68064 contains a list of PDF Full Texts available from EurekaMag.





Protein Misfolding in Disease and Small Molecule Therapies
, Current Topics in Medicinal Chemistry 12(22): 2460-2469 (2013)

Phenylalanine Hydroxylase Misfolding and Pharmacological Chaperones
, Current Topics in Medicinal Chemistry 12(22): 2534-2545 (2013)

Sod1 Aggregation and Als: Role of Metallation States and Disulfide Status
, Current Topics in Medicinal Chemistry 12(22): 2560-2572 (2013)

Copper and Heme-Mediated Abeta Toxicity: Redox Chemistry, Abeta Oxidations and Anti-Ros Compounds
, Current Topics in Medicinal Chemistry 12(22): 2573-2595 (2013)

Alpha-Emitters for Immuno-Therapy: A Review of Recent Developments from Chemistry to Clinics
, Current Topics in Medicinal Chemistry 12(23): 2642-2654 (2013)

Tetraamine-Coupled Peptides and Resulting 99mTc-Radioligands: An Effective Route for Receptor-Targeted Diagnostic Imaging of Human Tumors
, Current Topics in Medicinal Chemistry 12(23): 2655-2667 (2013)

Classification Models for Anticancer Activity
, Current Topics in Medicinal Chemistry 12(24): 2705-2726 (2013)

Computational Tools in the Discovery of New G-Quadruplex Ligands with Potential Anticancer Activity
, Current Topics in Medicinal Chemistry 12(24): 2843-2856 (2013)

Allosteric Drugs and Seven Transmembrane Receptors
, Current Topics in Medicinal Chemistry 13(1): 5-13 (2013)

Protein Interface Pharmacophore Mapping Tools for Small Molecule Protein: Protein Interaction Inhibitor Discovery
, Current Topics in Medicinal Chemistry 13(9): 989-1001 (2013)

Structure Guided Design of Biotin Protein Ligase Inhibitors for Antibiotic Discovery
, Current Topics in Medicinal Chemistry 14(1): 4-20 (2013)

New Synthetic Antibiotics for the Treatment of Enterococcus and Campylobacter Infection
, Current Topics in Medicinal Chemistry 14(1): 21-39 (2013)

Designing Type Ii Topoisomerase Inhibitors: A Molecular Modeling Approach
, Current Topics in Medicinal Chemistry 14(1): 40-50 (2013)

Structure-and-Mechanism-Based Design and Discovery of Type Ii Mycobacterium Tuberculosis Dehydroquinate Dehydratase Inhibitors
, Current Topics in Medicinal Chemistry 14(1): 51-63 (2013)

Docking and Pls Studies on a Set of Thiophenes Rna Polymerase Inhibitors Against Staphylococcus aureus
, Current Topics in Medicinal Chemistry 14(1): 64-80 (2013)

Prospects for Developing New Antibacterials Targeting Bacterial Type Iia Topoisomerases
, Current Topics in Medicinal Chemistry 14(1): 130-151 (2013)

Computational Medicinal Chemistry for Rational Drug Design: Identification of Novel Chemical Structures with Potential Anti-Tuberculosis Activity
, Current Topics in Medicinal Chemistry 14(1): 176-188 (2013)

Alkaloids as Important Scaffolds in Therapeutic Drugs for the Treatments of Cancer, Tuberculosis, and Smoking Cessation
, Current Topics in Medicinal Chemistry 14(2): 239-252 (2013)

Reviewing Colchicaceae Alkaloids Perspectives of Evolution on Medicinal Chemistry
, Current Topics in Medicinal Chemistry 14(2): 274-289 (2013)

The Emerging Role of Nras Mutations in Colorectal Cancer Patients Selected for Anti-Egfr Therapies
, Reviews on Recent Clinical Trials 9(1): 8-12 (2014)

Computational Studies of Free Radical-Scavenging Properties of Phenolic Compounds
, Current Topics in Medicinal Chemistry 15(2): 85-104 (2015)

Computational and Experimental Advances in Drug Repositioning for Accelerated Therapeutic Stratification
, Current Topics in Medicinal Chemistry 15(1): 5-20 (2015)

?v?3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology
, Current Topics in Medicinal Chemistry 16(3): 314-329 (2015)

Antimicrobial Peptides and their Pore/Ion Channel Properties in Neutralization of Pathogenic Microbes
, Current Topics in Medicinal Chemistry 16(1): 46-53 (2015)

Magainin 2-Pgla Interactions in Membranes - Two Peptides that Exhibit Synergistic Enhancement of Antimicrobial Activity
, Current Topics in Medicinal Chemistry 16(1): 65-75 (2015)

Model Membrane and Cell Studies of Antimicrobial Activity of Melittin Analogues
, Current Topics in Medicinal Chemistry 16(1): 40-45 (2015)

Structure-Function Relationships of Antimicrobial Peptides and Proteins with Respect to Contact Molecules on Pathogen Surfaces
, Current Topics in Medicinal Chemistry 16(1): 89-98 (2015)

Non-Membrane Permeabilizing Modes of Action of Antimicrobial Peptides on Bacteria
, Current Topics in Medicinal Chemistry 16(1): 76-88 (2015)

Naturally Occurring Peptides from Rana temporaria: Antimicrobial Properties and More
, Current Topics in Medicinal Chemistry 16(1): 54-64 (2015)

Interactions of Antimicrobial Peptides with Bacterial Membranes and Membrane Components
, Current Topics in Medicinal Chemistry 16(1): 16-24 (2015)

Antimicrobial Peptide Structure and Mechanism of Action: A Focus on the Role of Membrane Structure
, Current Topics in Medicinal Chemistry 16(1): 25-39 (2015)

Mammalian Antimicrobial Peptides: Promising Therapeutic Targets Against Infection and Chronic Inflammation
, Current Topics in Medicinal Chemistry 16(1): 99-129 (2015)

Nmr Structures and Interactions of Antimicrobial Peptides with Lipopolysaccharide: Connecting Structures to Functions
, Current Topics in Medicinal Chemistry 16(1): 4-15 (2015)

Novel Hiv-1 Integrase Inhibitor Development by Virtual Screening Based on Qsar Models
, Current Topics in Medicinal Chemistry 16(4): 441-448 (2015)

Inhibition of Shikimate Kinase and Type Ii Dehydroquinase for Antibiotic Discovery: Structure-Based Design and Simulation Studies
, Current Topics in Medicinal Chemistry 16(9): 960-977 (2015)

Perspectives in Medicinal Chemistry:
, Current Topics in Medicinal Chemistry 16(4): 381-382 (2015)

Perspectives in Medicinal Chemistry: Metalloprotein Inhibitors: What Have We Made and What is the Next Step?
, Current Topics in Medicinal Chemistry 16(5): 467-469 (2015)

Emerging Advances in Nanomedicine as a Nanoscale Pharmacotherapy in Rheumatoid Arthritis: State of the Art
, Current Topics in Medicinal Chemistry 17(2): 162-173 (2016)

Perspectives in Medicinal Chemistry: Focusing on the Link between Diabetes, Alzheimer's Disease and Cancer for the Discovery of New Medicines
, Current Topics in Medicinal Chemistry 16(7): 675-676 (2015)

Perspectives in Medicinal Chemistry: Dna Methylation and Demethylation Mechanisms as Therapeutic Targets?
, Current Topics in Medicinal Chemistry 16(8): 807-808 (2015)

Perspective in Medicinal Chemistry: Structure-Based Drug Design
, Current Topics in Medicinal Chemistry 17(2): 93-94 (2016)

Hiv-Challenges for Human
, Current Topics in Medicinal Chemistry 18(25): 2136-2137 (2019)

New Experimental and Computational Tools for Drug Discovery: Medicinal Chemistry, Personalized Medicine, Ethical & Legal Issues Part-V
, Current Topics in Medicinal Chemistry 18(25): 2141-2142 (2019)

Computer Aided Drug Design for Combating Diseases (Part-Ii)
, Current Topics in Medicinal Chemistry 18(31): 2631-2632 (2019)

Computer Aided Drug Design for Combating Diseases (Part-Iii)
, Current Topics in Medicinal Chemistry 18(32): 2741-2742 (2019)

A Survey of the Anti-microbial Properties of Naturally Occurring Prenyloxyphenylpropanoids and Related Compounds
, Current Topics in Medicinal Chemistry 18(24): 2097-2101 (2019)

Advancement in Microbial Cheminformatics
, Current Topics in Medicinal Chemistry 18(29): 2459-2461 (2019)

MicroRnas as Therapeutic Agents: The Future of the Battle Against Cancer
, Current Topics in Medicinal Chemistry 18(30): 2544-2554 (2019)

Current Practice and New Developments in the Use of In Vivo Magnetic Resonance Spectroscopy for the Assessment of Key Metabolites Implicated in the Pathophysiology of Schizophrenia
, Current Topics in Medicinal Chemistry 18(21): 1908-1924 (2019)

Gpcr Allosteric Modulators: Mechanistic Advantages and Therapeutic Applications
, Current Topics in Medicinal Chemistry 18(23): 2002-2006 (2019)

Microglial Proteases: Strategic Targets for Neuroprotective Agents
, Current Neuropharmacology 1(1): 99-108 (2003)

Cannabinoid Signaling in Glial Cells in Health and Disease
, Current Neuropharmacology 2(1): 115-124 (2004)

Cannabinoid Function in Spatial Learning: An Update
, Current Neuropharmacology 2(1): 125-143 (2004)

Cannabinoid Receptor Activation and the Endocannabinoid System in the Gastrointestinal Tract
, Current Neuropharmacology 2(1): 91-102 (2004)

Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function
, Current Neuropharmacology 3(1): 9-34 (2005)

Partial Dopamine Agonists and the Treatment of Psychosis
, Current Neuropharmacology 3(1): 3-8 (2005)

Gender Differences in Pharmacokinetics and Side Effects of Second Generation Antipsychotic Drugs
, Current Neuropharmacology 3(1): 73-85 (2005)

Cerebral Arachidonate Cascade in Dementia: Alzheimers Disease and Vascular Dementia
, Current Neuropharmacology 4(1): 87-100 (2006)

Parkinsons Disease: Genetics and Beyond
, Current Neuropharmacology 5(2): 99-113 (2007)

The Development of Rapastinel (Formerly Glyx-13); A Rapid Acting and Long Lasting Antidepressant
, Current Neuropharmacology 15(1): 47-56 (2016)

Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges
, Current Neuropharmacology 17(1): 33-58 (2018)

The Genomic Approaches to Major Depression
, Current Pharmacogenomics 1(1): 67-74 (2003)

Pharmacogenetics of Selective Serotonin Reuptake Inhibitor Response in Major Depression
, Current Pharmacogenomics 1(1): 1-7 (2003)

Hla Peptide-mediated Strategies for Modulation of Cellular and Humoral Immune Response in Transplantation
, Current Pharmacogenomics 1(1): 17-36 (2003)

Genomic and Proteomic Techniques and their Application in Selenium Research
, Current Pharmacogenomics 1(1): 59-65 (2003)

Genetic Polymorphism and Tumor Immunotherapy
, Current Pharmacogenomics 1(1): 37-57 (2003)

Biological and Clinical Significance of Polymorphisms in Nad(P)H: Quinone Oxidoreductase 1 (Nqo1)
, Current Pharmacogenomics 2(1): 75-82 (2004)

Genes, Environment, Intermediate Phenotypes, and the Pathogenesis of Diabetic Nephropathy
, Current Pharmacogenomics 2(1): 61-74 (2004)

Pharmacogenetics of the Human Mdr1 Multidrug Transporter
, Current Pharmacogenomics 2(1): 1-11 (2004)

Biology of Protooncogene c-kit Receptor and Spermatogenesis
, Current Pharmacogenomics 2(1): 47-60 (2004)

Candidate Genes in the Pharmacogenomics of Antihypertensive Treatment - A Review and Future Aspects
, Current Pharmacogenomics 2(1): 83-112 (2004)

High-throughput Genotyping Methods for Pharmacogenomic Studies
, Current Pharmacogenomics 2(1): 21-33 (2004)

Therapeutic Options in Prevention and Treatment of Aspartoacylase Gene Mutation Resulting Abnormalities in Canavan Disease
, Current Pharmacogenomics 2(1): 13-20 (2004)

Carotenoids and Modulation of Cancer: Molecular Targets
, Current Pharmacogenomics 2(1): 35-45 (2004)

Influence of Cyp2D6 Genetics on Opioid Kinetics, Metabolism and Response
, Current Pharmacogenomics 3(1): 43-52 (2005)

Multigenic Control of Drug Response and Regulatory Decision-Making in Pharmacogenomics: The Need for an Upper-Bound Estimate of Genetic Contributions
, Current Pharmacogenomics 3(1): 53-71 (2005)

Application of Pharmacogenomic Approaches in the Study of Drug Response in Complex Diseases
, Current Pharmacogenomics 3(3): 177-190 (2005)

Dna Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy
, Current Pharmacogenomics 3(4): 289-304 (2005)

Pharmacogenetics in Type 2 Diabetes: Polymorphisms in Candidate Genes Affecting Responses to Antidiabetic Oral Treatment
, Current Pharmacogenomics 4(1): 69-78 (2006)

Information of Adme-Associated Proteins and Potential Application for Pharmacogenetic Prediction of Drug Responses
, Current Pharmacogenomics 4(2): 87-103 (2006)

Effect of Brain Derived Neurotrophic Factor (Bdnf) Gene Variants on Therapeutic Response and the Risk for Schizophrenia
, Current Pharmacogenomics 4(2): 169-175 (2006)

Pharmacogenetics in Affective Disorders: A Drug Response Approach
, Current Pharmacogenomics 4(3): 191-208 (2006)

Will Pharmacogenetics Predict Response to Therapies in Rheumatoid Arthritis?
, Current Pharmacogenomics 4(4): 307-319 (2006)

Structural and Functional Organization of miRnas
, Current Pharmacogenomics 5(2): 157-166 (2007)

Using Pharmacogenomic Tumor Profiling to Identify Biomarkers of 5-fluorouracil Response in Colorectal Cancer
, Current Pharmacogenomics 5(3): 167-177 (2007)

Analysis of the Molecular Determinants of the Response of Chronic Myelogenous Leukaemia to Tyrosine Kinase Inhibitors
, Current Pharmacogenomics 5(3): 201-213 (2007)

Role of the Growth Suppressor p27Kip1 During Vascular Remodeling
, Current Vascular Pharmacology 1(1): 99-106 (2003)

The Influence of Sex Hormones on Pulmonary Vascular Reactivity: Possible Vasodilator Therapies for the Treatment of Pulmonary Hypertension
, Current Vascular Pharmacology 4(1): 9-15 (2006)

Pharmacological Management of No Reflow During Percutaneous Coronary Intervention
, Current Vascular Pharmacology 4(2): 95-100 (2006)

Inflammation, Sleep, Obesity and Cardiovascular Disease
, Current Vascular Pharmacology 5(2): 93-102 (2007)

Novel Anti-Arrhythmic Drugs for Atrial Fibrillation Management
, Current Vascular Pharmacology 5(3): 185-194 (2007)

Cannabinoids and Cardiovascular Disease: The Outlook for Clinical Treatments
, Current Vascular Pharmacology 5(3): 175-184 (2007)

Models to Study Atherosclerosis: A Mechanistic Insight
, Current Vascular Pharmacology 7(1): 75-109 (2009)

Purines as Neurotransmitters and Neuromodulators in Blood Vessels
, Current Vascular Pharmacology 7(1): 3-14 (2009)

Emerging P2Y12 Receptor Antagonists: Role in Coronary Artery Disease
, Current Vascular Pharmacology 8(1): 93-101 (2010)

Factor Xa Inhibitors in Acute Coronary Syndromes and Venous Thromboembolism
, Current Vascular Pharmacology 8(1): 5-11 (2010)

Role of Innate Immune System in Inflammation and Cardiac Remodeling After Myocardial Infarction
, Current Vascular Pharmacology 13(1): 20-25 (2015)

The Meaning of Different Forms of Structural Myocardial Injury, Immune Response and Timing of Infarct Necrosis and Cardiac Repair
, Current Vascular Pharmacology 13(1): 6-19 (2015)

Sympathetic Overactivity in Hypertension and Cardiovascular Disease
, Current Vascular Pharmacology 12(1): 4-15 (2014)

Ca 2+ Signalling in Endothelial Progenitor Cells: A Novel Means to Improve Cell-Based Therapy and Impair Tumour Vascularisation
, Current Vascular Pharmacology 12(1): 87-105 (2014)

Inflammaging and Proteases in Abdominal Aortic Aneurysm
, Current Vascular Pharmacology 13(1): 95-110 (2015)

Is Targeting microRnas the Philosopher's Stone for Vascular Disease?
, Current Vascular Pharmacology 14(1): 88-97 (2015)

The Tree of Sirtuins and the Garden of Cardiovascular Youth
, Current Vascular Pharmacology 14(1): 80-87 (2015)

The Pharmacogenomics of Anti-Platelet Intervention (Papi) Study: Variation in Platelet Response to Clopidogrel and Aspirin
, Current Vascular Pharmacology 14(1): 116-124 (2015)

Anti-inflammatory strategies in stroke: a potential therapeutic target
, Current Vascular Pharmacology 14(1): 98-105 (2015)

Cellular and Molecular Mechanisms of Low Cardiac Output Syndrome after Pediatric Cardiac Surgery
, Current Vascular Pharmacology 14(1): 5-13 (2015)

Pathophysiology of Post-Operative Low Cardiac Output Syndrome
, Current Vascular Pharmacology 14(1): 14-23 (2015)

Theoretical and Evidence-Based Benefit of Afterload Reduction in the Postoperative Pediatric Heart
, Current Vascular Pharmacology 14(1): 24-28 (2015)

A Review of Systemic Vasodilators in Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery
, Current Vascular Pharmacology 14(1): 29-36 (2015)

Pulmonary Vasodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery
, Current Vascular Pharmacology 14(1): 37-47 (2015)

Inodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery
, Current Vascular Pharmacology 14(1): 48-57 (2015)

Pharmacological Manipulation of Peripheral Vascular Resistance in Single Ventricle Patients (Stages I, Ii, and Iii of Palliation)
, Current Vascular Pharmacology 14(1): 58-62 (2015)

Pharmacological manipulation of peripheral vascular resistance in special clinical situations after pediatric cardiac surgery
, Current Vascular Pharmacology 14(1): 63-72 (2015)

A hypothesis for the role of Reck in angiogenesis
, Current Vascular Pharmacology 14(1): 106-115 (2015)

Renoprotective Effects of Sglt2 Inhibitors: Beyond Glucose Reabsorption Inhibition
, Current Vascular Pharmacology 15(2): 96-102 (2017)

Matrix Metalloproteinases as Markers of Atherosclerosis in Renal Patients: Are we there Yet?
, Current Vascular Pharmacology 17(1): 50-51 (2018)

The Plasma Coagulation Cascade: Potential Targets for Novel Anticoagulants in Major Lower Limb Surgery
, Current Vascular Pharmacology 9(1): 3-10 (2011)

Ezetimibe and Vascular Inflammation
, Current Vascular Pharmacology 9(1): 99-108 (2011)

The Role of Nitric Oxide on Endothelial Function
, Current Vascular Pharmacology 10(1): 4-18 (2012)

Lifestyle Factors and Endothelial Function
, Current Vascular Pharmacology 10(1): 94-106 (2012)

Measuring the Infectiousness of Persons with Hiv-1: Opportunities for Preventing Sexual Hiv-1 Transmission
, Current Hiv Research 1(1): 69-89 (2003)

Hiv-2 Infection and Chemokine Receptors Usage - Clues to Reduced Virulence of Hiv-2
, Current Hiv Research 3(1): 3-16 (2005)

Affordable Antiretroviral Drugs for the Under-Served Markets: How to Expand Equitable Access Against the Backdrop of Challenging Scenarios?
, Current Hiv Research 4(1): 3-20 (2006)

Diabetes Case Identification Methods Applied to Electronic Medical Record Systems: Their Use in Hiv-Infected Patients
, Current Hiv Research 4(1): 97-106 (2006)

Hiv-1 Ctl-Based Vaccine Immunogen Selection: Antigen Diversity and Cellular Response Features
, Current Hiv Research 5(1): 97-107 (2007)

The Hiv-1 Tat Protein Stimulates Reverse Transcription In Vitro
, Current Hiv Research 5(5): 474-483 (2007)





赢8娱乐糖果配对游戏 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>